Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Delgocitinib by Leo Pharma for Hand Dermatitis: Likelihood of Approval
Delgocitinib is under clinical development by Leo Pharma and currently in Pre-Registration for Hand Dermatitis. According to GlobalData, Pre-Registration drugs...
Ingenol mebutate by Leo Pharma for Basal Cell Carcinoma (Basal Cell Epithelioma): Likelihood of Approval
Ingenol mebutate is under clinical development by Leo Pharma and currently in Phase II for Basal Cell Carcinoma (Basal Cell...
LEO-152020 by Leo Pharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
LEO-152020 is under clinical development by Leo Pharma and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...
Temtokibart by Leo Pharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Temtokibart is under clinical development by Leo Pharma and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...